Abstract
A low metastatic, thioguanine-resistant murine T lymphoma line (EbTGR) was hybridized in vitro, with the help of polyethylene glycol, with syngeneic bone marrow-derived macrophages. Two HAT-resistant hybrid lines (Eb-F1 and Eb-F2) were obtained from independent fusion cultures. A cytogenetic analysis revealed that most of the macrophage chromosomes except No. 12 had segregated or become rearranged 60 d after fusion, a time at which the cell lines had become stabilized in culture. Syngeneic mice inoculated subcutaneously with the tumor macrophage hybrid lines developed, very quickly, visceral metastases and died after less than 2 wk, while those inoculated with the parental line lived for greater than 6 wk and developed only localized, large primary tumors. The metastatic hybridomas expressed a similar tumor antigen as a spontaneous, in vivo derived, high metastatic variant (ESb) of the same tumor. This suggests that ESb cells might have arisen from a spontaneous fusion with a host macrophage.
Full Text
The Full Text of this article is available as a PDF (577.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altevogt P., Kurnick J. T., Kimura A. K., Bosslet K., Schirrmacher V. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant. Eur J Immunol. 1982 Apr;12(4):300–307. doi: 10.1002/eji.1830120409. [DOI] [PubMed] [Google Scholar]
- Ber R., Wiener F., Fenyö E. M. Proof of in vivo fusion of murine tumor cells with host cells by universal fusers. J Natl Cancer Inst. 1978 Apr;60(4):931–933. doi: 10.1093/jnci/60.4.931. [DOI] [PubMed] [Google Scholar]
- Bosslet K., Schirrmacher V., Shantz G. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro. Int J Cancer. 1979 Sep 15;24(3):303–313. doi: 10.1002/ijc.2910240306. [DOI] [PubMed] [Google Scholar]
- Brahe C., Serra A. A simple method for fusing human lymphocytes with rodent cells in monolayer by polyethylene glycol. Somatic Cell Genet. 1981 Jan;7(1):109–115. doi: 10.1007/BF01544752. [DOI] [PubMed] [Google Scholar]
- De Baetselier P., Gorelik E., Eshhar Z., Ron Y., Katzav S., Feldman M., Segal S. Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst. 1981 Nov;67(5):1079–1087. [PubMed] [Google Scholar]
- Dzarlieva R., Schirrmacher V., Fusenig N. F. Cytogenetic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model system. Int J Cancer. 1982 Nov 15;30(5):633–642. doi: 10.1002/ijc.2910300514. [DOI] [PubMed] [Google Scholar]
- Heppner G. H., Miller B. E. Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev. 1983;2(1):5–23. doi: 10.1007/BF00046903. [DOI] [PubMed] [Google Scholar]
- Kerbel R. S., Lagarde A. E., Dennis J. W., Donaghue T. P. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol. 1983 Apr;3(4):523–538. doi: 10.1128/mcb.3.4.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meerpohl H. G., Lohmann-Matthes M. L., Fischer H. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF). Eur J Immunol. 1976 Mar;6(3):213–217. doi: 10.1002/eji.1830060313. [DOI] [PubMed] [Google Scholar]
- Parr I. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. Br J Cancer. 1972 Jun;26(3):174–182. doi: 10.1038/bjc.1972.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schirrmacher V., Bosslet K. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. X. Immunoselection of tumor variants differing in tumor antigen expression and metastatic capacity. Int J Cancer. 1980 Jun 15;25(6):781–788. doi: 10.1002/ijc.2910250614. [DOI] [PubMed] [Google Scholar]
- Schirrmacher V., Jacobs W. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fc gamma receptors on metastatic tumor cell variants. J Supramol Struct. 1979;11(1):105–111. doi: 10.1002/jss.400110111. [DOI] [PubMed] [Google Scholar]
- Schirrmacher V., Shantz G., Clauer K., Komitowski D., Zimmermann H. P., Lohmann-Matthes M. L. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer. 1979 Feb;23(2):233–244. doi: 10.1002/ijc.2910230215. [DOI] [PubMed] [Google Scholar]
- Schirrmacher V. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice. Int J Cancer. 1979 Jul 15;24(1):80–86. doi: 10.1002/ijc.2910240114. [DOI] [PubMed] [Google Scholar]